Our study systematically elucidates the pivotal role of endothelial cells in the glycolytic reprogramming associated with PCOS, and identifies PLK2 as a key regulatory factor linking endothelial dysfunction, enhanced glycolysis, and immune imbalance. This evidence concerns the gene PLK2 and polycystic ovary syndrome.